Chimeras could help in the fight against leptospirosis.

Elife

Laboratório Especial de Desenvolvimento de Vacinas-Centro de Biotecnologia, Instituto Butantan, São Paulo, Brazil.

Published: January 2018

Understanding the structure of an antigen can guide the design of improved antigen-based vaccines.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5774897PMC
http://dx.doi.org/10.7554/eLife.34087DOI Listing

Publication Analysis

Top Keywords

chimeras help
4
help fight
4
fight leptospirosis
4
leptospirosis understanding
4
understanding structure
4
structure antigen
4
antigen guide
4
guide design
4
design improved
4
improved antigen-based
4

Similar Publications

Rationalize the Functional Roles of Protein-Protein Interactions in Targeted Protein Degradation by Kinetic Monte Carlo Simulations.

J Phys Chem B

December 2024

Department of Systems and Computational Biology, Albert Einstein College of Medicine, 1300 Morris Park Avenue, Bronx, New York 10461, United States.

Targeted protein degradation is a promising therapeutic strategy to tackle disease-causing proteins that lack binding pockets for traditional small-molecule inhibitors. Its first step is to trigger the proximity between a ubiquitin ligase complex and a target protein through a heterobifunctional molecule, such as proteolysis targeting chimeras (PROTACs), leading to the formation of a ternary complex. The properties of protein-protein interactions play an important regulatory role during this process, which can be reflected by binding cooperativity.

View Article and Find Full Text PDF

Greenbeards facilitate cooperation by encoding a perceptible signal, the ability to detect it, and a tendency to help others that display it. Falsebeards are hypothetical cheaters that display the signal without being altruistic. Despite many examples of greenbeards, evidence for falsebeards is scarce.

View Article and Find Full Text PDF

Proteolysis Targeting Chimera Agents (PROTACs): New Hope for Overcoming the Resistance Mechanisms in Oncogene-Addicted Non-Small Cell Lung Cancer.

Int J Mol Sci

October 2024

Medical Oncology Unit, Fondazione Istituti di Ricovero e Cura a Carattere Scientifico (IRCCS) San Gerardo dei Tintori, 20900 Monza, Italy.

Non-small cell lung cancer (NSCLC) remains a disease with a poor prognosis despite the advances in therapies. NSCLC with actionable oncogenic alterations represent a subgroup of diseases for which tyrosine kinase inhibitors (TKIs) have shown relevant and robust impact on prognosis, both in early and advanced stages. While the introduction of powerful TKIs increases the ratio of potentially curable patients, the disease does develop resistance over time through either secondary mutations or bypass activating tracks.

View Article and Find Full Text PDF

Targeted protein degradation is a promising therapeutic strategy to tackle disease-causing proteins that lack binding pockets for traditional small-molecule inhibitors. Its first step is to trigger the proximity between a ubiquitin ligase complex and a target protein through a heterobifunctional molecule, such as proteolysis targeting chimeras (PROTACs), leading to the formation of a ternary complex. The properties of protein-protein interactions play an important regulatory role during this process, which can be reflected by binding cooperativity.

View Article and Find Full Text PDF

Bacterial ghosts engineered with lipidated antigens as an adjuvant-free vaccine for Chlamydia abortus.

Int J Pharm

December 2024

State Key Laboratory for Animal Disease Control and Prevention, College of Veterinary Medicine, Lanzhou University, Lanzhou Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Lanzhou 730000, China; Gansu Province Research Center for Basic Disciplines of Pathogen Biology, Lanzhou 730046, China. Electronic address:

Article Synopsis
  • Bacterial ghosts (BGs) are promising candidates for vaccine delivery due to their natural ability to enhance immune responses and effectively deliver antigens.
  • In this study, researchers modified an E. coli ghost with a protective antigen from Chlamydia abortus, which boosted the ghost's ability to present the antigen to immune cells and activate them.
  • The modified ghosts showed improved immune responses in a mouse model, leading to better clearance of Chlamydia abortus infections and less damage to the uterus, suggesting a potential for developing a universal adjuvant-free vaccine platform.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!